Skip to main content
Equibles
CYRX logo

CYRX · Cryoport, Inc. · Earnings Call Transcripts & Audio

Track CYRX — free

Use CYRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CYRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$15.96 +0.41 (+2.64%)
Russell 2000 member Rebalance outlook locked
Market Cap
$803.55M
Shares
50.65M

Cryoport, Inc. Earnings Call Transcripts

Quarterly earnings calls for Cryoport, Inc. (CYRX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲6.7% $60.46M −$5.32M '22 Q3 22-11-03 ▲6.9% $60.36M −$9.44M '22 Q4 23-02-23 ▲20.1% $62.82M −$5.57M '23 Q1 23-05-04 ▼11.1% $57.02M −$18.36M '23 Q2 23-08-09 ▼7.1% $56.16M −$13.27M '23 Q3 23-11-08 ▼112.1% $ −$62.39M '23 Q4 24-03-12 ▼40.6% $37.29M −$18.89M '24 Q1 24-05-07 ▼30.4% $39.71M −$77.99M '24 Q2 24-08-06 ▼31.8% $38.32M $805,000 '24 Q3 24-11-07 · $41.45M −$18.68M '24 Q4 25-03-04 ▲10.1% $41.04M −$11.98M '25 Q1 25-05-07 ▲14.5% $45.45M $108.87M '25 Q2 25-08-06 ▲15.4% $44.23M −$6.94M '25 Q3 25-11-04 ▲9.6% $45.45M −$11.64M '25 Q4 26-03-03 ▲16.5% $47.80M −$10.54M '26 Q1 26-05-04 LATEST ▲7.7% $48.97M −$8.26M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Cryoport, Inc. (CYRX) Q2 2026 Earnings Call Transcript
Confident tone Revenue growth and guidance Cell and gene therapy commercial and clinical growth IntegraCell cryopreservation services
Revenue
$48.97M
▲ 7.7% YoY
Diluted EPS
$-0.20
▼ 109.4% YoY
Gross margin
46.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Cryoport, Inc. (CYRX) Q1 2026 Earnings Call Transcript
Confident tone Cell and gene therapy commercial pipeline Revenue growth and segment performance IntegraCell cell therapy manufacturing
Revenue
$47.80M
▲ 16.5% YoY
Diluted EPS
$-0.25
Gross margin
45.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Cryoport, Inc. (CYRX) Q4 2025 Earnings Call Transcript
Positive tone MVE Biological Solutions and cryogenic products Commercial cell and gene therapy revenue growth Financial performance and guidance
Revenue
$45.45M*
▲ 9.6% YoY
Gross margin
47.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript
Confident tone Life Sciences Products / MVE cryogenic systems Cell and gene therapy commercial support growth Life Sciences Services segment performance
Revenue
$44.23M
▲ 15.4% YoY
Diluted EPS
$-0.18
Gross margin
48.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript
Confident tone MVE Products and Animal Health Demand Pathway to Profitability and Margin Expansion FDA/Regulatory Headwinds and Client Setbacks
Revenue
$45.45M
▲ 14.5% YoY
Diluted EPS
$2.13
Gross margin
47.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript
Confident tone DHL Strategic Partnership Tariffs and Supply Chain Cell and Gene Therapy Commercial Growth
Revenue
$41.04M
▲ 10.1% YoY
Diluted EPS
$-0.28
Gross margin
45.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-04
Cryoport, Inc. (CYRX) Q4 2024 Earnings Call Transcript
Positive tone Cost management and gross margin improvement MVE / Life Sciences Products stabilization IntegriCell cryopreservation launch
Revenue
$41.45M*
Gross margin
47.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Cryoport, Inc. (CYRX) Q3 2024 Earnings Call Transcript
Positive tone Life Sciences Services growth Cost reduction and profitability IntegriCell and CRYOGENE expansion
Revenue
$38.32M
▼ 31.8% YoY
Diluted EPS
$-0.02
Gross margin
45.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Cryoport, Inc. (CYRX) Q2 2024 Earnings Call Transcript
Positive tone Path to Profitability and Adjusted EBITDA China Market Challenges Cell and Gene Therapy Commercial Ramp
Revenue
$39.71M
▼ 30.4% YoY
Diluted EPS
$-1.62
Gross margin
44.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Cryoport, Inc. (CYRX) Q1 2024 Earnings Call Transcript
Cautious tone MVE Cryogenic Systems Weakness BioStorage/BioServices Growth Cell and Gene Therapy Momentum
Revenue
$37.29M
▼ 40.6% YoY
Diluted EPS
$-0.43
Gross margin
40.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
Cryoport, Inc. (CYRX) Q4 2023 Earnings Call Transcript
Positive tone MVE Biological Solutions 2024 Guidance and Conservative Outlook CRYOPDP U.S. Expansion
Revenue
$*
▼ 112.1% YoY
Gross margin
10.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Cryoport, Inc. (CYRX) Q3 2023 Earnings Call Transcript
Revenue
$56.16M
▼ 7.1% YoY
Diluted EPS
$-0.31
Gross margin
43.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Cryoport, Inc. (CYRX) Q2 2023 Earnings Call Transcript
Revenue
$57.02M
▼ 11.1% YoY
Diluted EPS
$-0.42
Gross margin
43.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Cryoport, Inc. (CYRX) Q1 2023 Earnings Call Transcript
Revenue
$62.82M
▲ 20.1% YoY
Diluted EPS
$-0.16
Gross margin
43.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Cryoport, Inc. (CYRX) Q4 2022 Earnings Call Transcript
Revenue
$60.36M
▲ 6.9% YoY
Diluted EPS
$-0.24
Gross margin
43.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Cryoport, Inc. (CYRX) Q3 2022 Earnings Call Transcript
Revenue
$60.46M
▲ 6.7% YoY
Diluted EPS
$-0.15
Gross margin
43.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Cryoport, Inc. (CYRX) Q2 2022 Earnings Call Transcript
Revenue
$64.15M
▲ 14.2% YoY
Diluted EPS
$-0.23
Gross margin
45.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cryoport, Inc. (CYRX) Q1 2022 Earnings Call Transcript
Revenue
$52.30M
▼ 1.8% YoY
Diluted EPS
$-0.31
Gross margin
42.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Cryoport, Inc. (CYRX) Q4 2021 Earnings Call Transcript
Revenue
$56.44M
▲ 16.7% YoY
Diluted EPS
$-5.46
Gross margin
41.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Cryoport, Inc. (CYRX) Q3 2021 Earnings Call Transcript
Revenue
$56.69M
▲ 407.5% YoY
Diluted EPS
$-0.18
Gross margin
41.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Cryoport, Inc. (CYRX) Q2 2021 Earnings Call Transcript
Revenue
$56.19M
▲ 498.5% YoY
Diluted EPS
$-0.16
Gross margin
45.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Cryoport, Inc. (CYRX) Q1 2021 Earnings Call Transcript
Revenue
$53.28M
▲ 445.2% YoY
Diluted EPS
$-0.13
Gross margin
46.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-01-20
Cryoport, Inc. (CYRX) Q4 2020 Earnings Call Transcript
Revenue
$48.36M
▲ 423.3% YoY
Diluted EPS
$-1.32
Gross margin
41.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Cryoport, Inc. (CYRX) Q3 2020 Earnings Call Transcript
Revenue
$11.17M
▲ 16.6% YoY
Diluted EPS
$-0.29
Gross margin
54.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-07
Cryoport, Inc. (CYRX) Q2 2020 Earnings Call Transcript
Revenue
$9.39M
▲ 10.9% YoY
Diluted EPS
$-0.15
Gross margin
54.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Cryoport, Inc. (CYRX) Q1 2020 Earnings Call Transcript
Revenue
$9.77M
▲ 46.9% YoY
Diluted EPS
$-0.11
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-05
Cryoport, Inc. (CYRX) Q4 2019 Earnings Call
Revenue
$9.24M
▲ 62.4% YoY
Gross margin
53.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 earnings calls
Key facts CIK 1124524 CUSIP 229050307 13F (30d) 7 filings 7 filers Visit website Investor relations